Follow on Google News News By Tag Industry News * Healthcare * More Industries... News By Location Country(s) Industry News
Follow on Google News | New Market Report - OTC Healthcare Distribution in Russia, Poland, Ukraine, Romania and BulgarRussia, Poland, Ukraine, Romania and Bulgaria stand out as offering the highest potential growth for non-prescription consumer healthcare in Europe.
So says a new market report from James Dudley Management published this month - “OTC Distribution in Central and Eastern Europe’s Growth Markets - Grasping the Opportunities in Russia, Ukraine, Poland, Romania and Bulgaria” The non-prescription medicines’ market in Russia, Poland, Ukraine, Romania and Bulgaria has continued to perform better than most other European markets. The forecast based on current trends shows an average of over 6% a year for the five markets to 2014. While Russia and Ukraine’s non-prescription consumer healthcare markets are expected to show the strongest growth to 2015, only Romania will perform below the five country average. Pharmacies dominate the distribution of non-prescription OTC medicines in Russia, Poland, Ukraine, Romania and Bulgaria. Compared to Western European averages pharmacy density is much higher in the five Central and East European countries under study. The average number of citizens served per pharmacy in Western Europe is 3,536 compared to the equivalent average in the five CEE counties of 2,666. Bulgaria has the highest density of pharmacies serving just 1,890 citizens per pharmacy on average compared to Romania with the lowest density serving over 3,000 citizens per pharmacy. "The importance of OTC medicines and personal care to pharmacies in Russia, Poland, Ukraine, Romania and Bulgaria can only be emphasised", says James Dudley author of the market report. Whereas, prescription business represents almost 70% of the turnover and OTC sales 9% of the average Western pharmacy, prescription medicines account for less than half of the average pharmacy turnover in Russia, Ukraine and Bulgaria. In all five CEE countries under study the share of turnover taken by OTC non-prescription medicine sales are much higher than in the west. Sales of high quality personal care products especially dermo-cosmetics are also important sources of turnover in Russia, Romania and Bulgaria. Figure 1: % Average Pharmacy Turnover Represented by OTC Medicines Russia 33% Ukraine 39% Poland 24% Romania 14% Bulgaria 16% Source: OTC Distribution in Central and Eastern Europe’s Growth Markets James Dudley Management 2013 The report discusses the supply chain for consumer health products in Russia, Poland, Ukraine, Romania and Bulgaria and in particular the growth of pharmacy chains. The report explains that there are few restrictions affecting the growth of pharmacy chains in the five CEE countries under study. In Russia the top ten chains represent some 15.5% of the retail pharmacy market. Among the leaders are the wholly owned chains Rigla with 805 outlets, Apotheka 36.6 with 842 outlets and A5 with 1,371 outlets. There are also a few significant virtual pharmacy chains in Russia. These are independent pharmacies affiliated to a group which behaves like a chain. These include Alphega, a group formed around the distributor Alliance Boots with 720 outlets, and two smaller groups Asna and UMG. In Ukraine the top ten chains represent 17.6% of the retail pharmacy market. By and large Ukraine pharmacy chains are smaller on average than in Russia for example Med-service has 314 outlets, Pharmastore has 131 outlets and Bazhaemo Health with just 95 stores. In Poland the largest pharmacy chain is Doz SA which controls over 2,000 pharmacies under its trade name Dbam o Zdrowie in Poland. These include wholly owned stores, franchise outlets and over 1,200 partner pharmacies. DOZ S.A. also runs the largest online pharmacy in Poland – www.doz.pl. ACP Pharma, the Polish wholesaler owned by Mediq in the Netherlands, has become the second largest private retail chain, Mediq Apteka. The company is also establishing a number of franchised outlets within its pharmacy chain. Other significant pharmacy chains in Poland are Dr Max (Penta) and Euro Apteka (EBA Grupe). Both chains are run by investment companies with international retail development ambitions across Central and East European States. Significant virtual pharmacy chains in Poland include the previously mentioned mixed format group Dbam o Zdrowie (Doz SA) and also groups affiliated to the big distributors Farmacol and Neuca (Torfarm). According to author of the Report James Dudley - “53% of pharmacies in Poland are members of virtual marketing chains”. In Romania the top three pharmacy chains are Sensiblu, Catena and Farmaciile Dona. In comparison to the other four markets under study pharmacy chains in Bulgaria are made up of small numbers of pharmacy branches. The largest is Mareshki with 170 outlets but others such as Astra and Apteka 36.6 have less than 20 branches each. The Dudley report also analyses the structure and trends amnog pharmaceutical Distributors in Russia, Poland, Ukraine, Romania and Bulgaria Historically there have been large numbers of pharmaceutical distributors and importers in the five countries under study. In Russia for example there are some 1,500 wholesalers and 700 importers and in Poland there are over 600 pharmaceutical distributors. That said, intermediary pharmaceutical distribution channels have concentrated around a handful of players in all five CEE countries covered by the Dudley report as the table below shows. Figure 2: Market Shares of the Leading Pharmaceutical Distributors in Russia, Poland, Ukraine, Romania and Bulgaria Country Russia Ukraine Poland Romania Bulgaria Source: OTC Distribution in Central and Eastern Europe’s Growth Markets James Dudley Management 2013 Details “OTC Distribution in Central and Eastern Europe’s Growth Markets - Grasping the Opportunities in Russia, Ukraine, Poland, Romania and Bulgaria” is published in PDF format by James Dudley Management May 2013. Visit http://www.james- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|